5,340
Views
295
CrossRef citations to date
0
Altmetric
TRENDS IN CLINICAL PRACTICE

Targeting the ERK signaling pathway in cancer therapy

&
Pages 200-211 | Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Keren Jiang, Meng Zhang, Fang Li, Donghua Li, Guirong Sun, Xiaojun Liu, Hong Li, Ruili Han, Ruirui Jiang, Zhuanjian Li, Xiangtao Kang & Fengbin Yan. (2017) Study on the role of gga-miRNA-200a in regulating cell differentiation and proliferation of chicken breast muscle by targeting Grb2. Animal Cells and Systems 21:6, pages 365-373.
Read now
Xinzhe Yu, Feng Yang, De-liang Fu & Chen Jin. (2016) L1 cell adhesion molecule as a therapeutic target in cancer. Expert Review of Anticancer Therapy 16:3, pages 359-371.
Read now
Tomomi Yamamoto-Fukuda, Naotaro Akiyama, Yasuaki Shibata, Haruo Takahashi, Tohru Ikeda, Michiaki Kohno & Takehiko Koji. (2014) KGFR as a possible therapeutic target in middle ear cholesteatoma. Acta Oto-Laryngologica 134:11, pages 1121-1127.
Read now
Roberto Ciarcia, Sara Damiano, Serena Montagnaro, Ugo Pagnini, Antonio Ruocco, Giuseppe Caparrotti, Danila d'Angelo, Silvia Boffo, Fátima Morales, Flavio Rizzolio, Salvatore Florio & Antonio Giordano. (2013) Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells. Cell Cycle 12:17, pages 2839-2848.
Read now
António E Pinto, Valeriano Leite & Jorge Soares. (2009) Clinical implications of molecular markers in follicular cell-derived thyroid cancer. Expert Review of Molecular Diagnostics 9:7, pages 679-694.
Read now
Paolo Miccoli, Mario Miccoli, Alessandro Antonelli & Michele N Minuto. (2009) Clinicopathologic and molecular disease prognostication for papillary thyroid cancer. Expert Review of Anticancer Therapy 9:9, pages 1261-1275.
Read now
Luigi Pasini, Margherita Y Turco, Lucilla Luzi, Ewa Aladowicz, Ernesta Fagiani & Luisa Lanfrancone. (2009) Melanoma: targeting signaling pathways and RaLP. Expert Opinion on Therapeutic Targets 13:1, pages 93-104.
Read now
Julie A Spicer. (2008) New small-molecule inhibitors of mitogen-activated protein kinase kinase. Expert Opinion on Drug Discovery 3:7, pages 801-817.
Read now
Wai M. Liu, Katherine A. Scott, Jonathan Shamash, Simon Joel & Thomas B. Powles. (2008) Enhancing the in vitro cytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach. Leukemia & Lymphoma 49:9, pages 1800-1809.
Read now
Michael J Baumann, Beda M Stadler & Monique Vogel. (2007) Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics. Expert Opinion on Medical Diagnostics 1:3, pages 409-421.
Read now

Articles from other publishers (285)

Manuel Jurado, Antonio Zorzano & Oscar Castaño. (2023) Cooperativity and oscillations: Regulatory mechanisms of K-Ras nanoclusters. Computers in Biology and Medicine 166, pages 107455.
Crossref
Thi Kim Chung Le, Xuan Dat Dao, Dang Vung Nguyen, Duc Huy Luu, Thi Minh Hanh Bui, Thi Huong Le, Huu Thang Nguyen, Tran Ngoan Le, Toshio Hosaka & Thi Thu Thao Nguyen. (2023) Insulin signaling and its application. Frontiers in Endocrinology 14.
Crossref
Wanrong Liao, Wang Fang & Juan Xu. (2023) Tripterine enhances regulatory effect of TNF- α on Caspase-3 and induces apoptosis of lung cancer cell . Materials Express 13:8, pages 1339-1345.
Crossref
Arturo Valle-Mendiola, Adriana Gutiérrez-Hoya & Isabel Soto-Cruz. (2023) JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. Genes 14:6, pages 1141.
Crossref
Shah Md. Toufiqur Rahman & Jason M. Haugh. (2023) On the inference of ERK signaling dynamics from protein biosensor measurements. Molecular Biology of the Cell 34:6.
Crossref
Emmanuelle M. Ruiz, Solomon A. Alhassan, Youssef Errami, Zakaria Y. Abd Elmageed, Jennifer S. Fang, Guangdi Wang, Margaret A. Brooks, Joe A. Abi-Rached, Emad Kandil & Mourad Zerfaoui. (2023) A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma. International Journal of Molecular Sciences 24:9, pages 8407.
Crossref
Zufa Sabeel, Youfeng Liang, Mingxuan Hao, Lu Ying, Rui Guo, Ruolan Chen, Xiaoning Li, Changyuan Yu & Zhao Yang. (2023) A comprehensive review of antitumor properties of Angelica species and their antitumor‐responsible constituents and the underlying molecular mechanisms involved in tumor inhibition . Phytotherapy Research 37:5, pages 2187-2211.
Crossref
Jindi Zeng, Jiancheng Wu, Shuijiao Pang, Feifei Wang, Xin Yu, Shouhua Zhang, Junquan Zeng, Jinlong Yan & Jianping Lian. (2023) Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway. Infectious Agents and Cancer 18:1.
Crossref
Yuan Gao & Pei Du. (2023) miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway. Molecular Biotechnology.
Crossref
C. J. A. Olde Hanhof, E. Dilmen, F. A. Yousef Yengej, F. Latta, C. M. E. Ammerlaan, J. Schreurs, L. Hooijmaijers, J. Jansen, M. B. Rookmaaker, I. Orhon, M. C. Verhaar & J. G. Hoenderop. (2023) Differentiated mouse kidney tubuloids as a novel in vitro model to study collecting duct physiology. Frontiers in Cell and Developmental Biology 11.
Crossref
Ying Chen, Lili Jiang, Lingli Xia, Gang Zhang & Lan Chen. (2022) ThPOK inhibits the immune escape of gastric cancer cells by inducing STPG1 to inactivate the ERK pathway. BMC Immunology 23:1.
Crossref
Jinying Gu, Qiuyu Wu, Qiuyue Zhang, Qidong You & Lei Wang. (2022) A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives. European Journal of Medicinal Chemistry 243, pages 114742.
Crossref
Acosta Gonzalez Herik Rodrigo, Nahoko Tomonobu, Haruka Yoneda, Rie Kinoshita, Yosuke Mitsui, Takuya Sadahira, Shin-ichi Terawaki, Yuma Gohara, Ni Luh Gede Yoni Komalasari, Fan Jiang, Hitoshi Murata, Ken-ichi Yamamoto, Junichiro Futami, Akira Yamauchi, Futoshi Kuribayashi, Yusuke Inoue, Eisaku Kondo, Shinichi Toyooka, Masahiro Nishibori, Masami Watanabe, Yasutomo Nasu & Masakiyo Sakaguchi. (2022) Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation. Biochemical and Biophysical Research Communications 634, pages 83-91.
Crossref
Akira Hirota, Jean-Emmanuel Clément, Satoshi Tanikawa, Takayuki Nonoyama, Tamiki Komatsuzaki, Jian Ping Gong, Shinya Tanaka & Masamichi Imajo. (2022) ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells. Cancers 14:23, pages 5890.
Crossref
Yang Yu, Yanling Zhao, Jongmin Choi, Zhongcheng Shi, Linjie Guo, John Elizarraras, Andy Gu, Feng Cheng, Yanxin Pei, Dai Lu, Muller Fabbri, Saurabh Agarwal, Chunchao Zhang, Sung Yun Jung, Jennifer H. Foster & Jianhua Yang. (2022) ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers 14:22, pages 5534.
Crossref
Sara Bartlome & Catherine Cecilia Berry. (2022) Recent insights into the effects of metabolism on breast cancer cell dormancy. British Journal of Cancer 127:8, pages 1385-1393.
Crossref
Sung‐Min Hwang, Yu‐Jin Ha, Gi‐Bang Koo, Hyun‐Jin Noh, A‐Yeon Lee, Byeong‐Ju Kim, Sun Mi Hong, Michael J. Morgan, Seong‐il Eyun, Dakeun Lee, Jae‐Seok Roe, Youngsoo Lee & You‐Sun Kim. (2022) LCK‐Mediated RIPK3 Activation Controls Double‐Positive Thymocyte Proliferation and Restrains Thymic Lymphoma by Regulating the PP2A‐ERK Axis. Advanced Science 9:32, pages 2204522.
Crossref
Yufei Long, Tuotuo Chong, Xiaoming Lyu, Lujia Chen, Xiaomin Luo, Oluwasijibomi Damola Faleti, Simin Deng, Fei Wang, Mingliang He, Zhipeng Qian, Hongli Zhao, Wenyan Zhou, Xia Guo, Ceshi Chen & Xin Li. (2022) FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Yi-Wen Chang, Chia-Chi Wang, Chieh-Fan Yin, Chang-Hsun Wu, Hsuan-Cheng Huang & Hsueh-Fen Juan. (2022) Quantitative phosphoproteomics reveals ectopic ATP synthase on mesenchymal stem cells to promote tumor progression via ERK/c-Fos pathway activation. Molecular & Cellular Proteomics 21:6, pages 100237.
Crossref
Haswanth Vundavilli, Aniruddha Datta, Chao Sima, Jianping Hua, Rosana Lopes, Michael Bittner, Tasha Miller & Heather M. Wilson-Robles. (2022) Anti-tumor effects of cryptotanshinone (C19H20O3) in human osteosarcoma cell lines. Biomedicine & Pharmacotherapy 150, pages 112993.
Crossref
Yu-Jeong Choi, Kangwook Lee, Ji-Hye Yoon, Sung-Gook Cho, Yun-Gyeong Kim, Miso Jeong, Hyun-Ha Hwang, Seo Yeon Lee, Se-Eun Jung & Seong-Gyu Ko. (2022) SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer. BioMed Research International 2022, pages 1-19.
Crossref
Chunxia Zhu, Shenqiu Ming, Bin Qiu & Hui Zhong. (2022) Research on Mechanism of FePt Nanoparticles at Varied Concentrations in Regulating DNA Injury and Inactivation of Hela Cells Through Mitogen-Activated Protein Kinase Signal Pathway. Science of Advanced Materials 14:5, pages 911-919.
Crossref
Haoping Lu, Huayu Yin, Linlin Qu, Xiaoxuan Ma, Rongzhan Fu & Daidi Fan. (2022) Ginsenoside Rk1 regulates glutamine metabolism in hepatocellular carcinoma through inhibition of the ERK/c-Myc pathway. Food & Function 13:7, pages 3793-3811.
Crossref
Anjiang Zhao, Dan Li, Xiongmin Mao, Mengliu Yang, Wuquan Deng, Wenjing Hu, Chen Chen, Gangyi Yang & Ling Li. (2022) GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling. Cell Death & Disease 13:3.
Crossref
Yuanyuan Liu, Yu Jiang, Yanfang Yang, Hongliang Wang, Jun Ye, Dongdong Liu, Yanmin Chen, Chunfang Lian, Renyun Wang, Yue Gao, Yingying Meng, Lili Gao & Yuling Liu. (2022) Houttuynia Essential Oil and its Self-Microemulsion Preparation Protect Against LPS-Induced Murine Mastitis by Restoring the Blood–Milk Barrier and Inhibiting Inflammation. Frontiers in Immunology 13.
Crossref
Anuradha Reddy, Tarang Jadav, Amit Kumar Sahu & Pinaki Sengupta. (2022) LC–MS/MS bioanalytical method for quantification of binimetinib and venetoclax, and their pharmacokinetic interaction. Bioanalysis 14:2, pages 75-86.
Crossref
Pei-Yu Hsu, Jiun-Liang Chen, Shun-Li Kuo, Wan-Ling Wang, Fei-Wen Jan, Sien-Hung Yang & Chia-Yu Yang. (2022) San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial–Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma. Integrative Cancer Therapies 21, pages 153473542211349.
Crossref
Sindhuja A Sindhuja A, Vimalavathini R Vimalavathini R & Kavimani S Kavimani S. (2021) In silico Docking Studies of Antiglycation Activity of Isorhamnetin on Molecular Proteins of Advanced Glycation end Product (AGE) Pathway. Biomedical and Pharmacology Journal 14:4, pages 2299-2306.
Crossref
Henrique Jorge Novaes Morgan, Aislan Quintiliano Delgado, Luiz Leonardo Saldanha, Nathalia Aparecida De Paula Camaforte, Anne Lígia Dokkedal & José Roberto Bosqueiro. (2021) Vochysia tucanorum Mart. butanol fraction presents antitumoral activity in vivo and prevents the installation of cachexia in solid Ehrlich tumor model. BMC Complementary Medicine and Therapies 21:1.
Crossref
Anna Kryshchyshyn-Dylevych, Lidia Radko, Nataliya Finiuk, Myroslav Garazd, Nataliya Kashchak, Andrzej Posyniak, Krzysztof Niemczuk, Rostyslav Stoika & Roman Lesyk. (2021) Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential. Bioorganic & Medicinal Chemistry 50, pages 116453.
Crossref
Sushma Maharjan, Yun-Suk Kwon, Min-Gu Lee, Kyu-Shik Lee & Kyung-Soo Nam. (2021) Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells. Pharmacological Reports 73:5, pages 1315-1327.
Crossref
Da-Bin Hwang, Shin-Young Kim, Dong-Hoon Won, Changuk Kim, Yoo-Sub Shin, Jong-Hwan Park, Young-Jin Chun, Kyung-Min Lim & Jun-Won Yun. (2021) Egr1 Gene Expression as a Potential Biomarker for In Vitro Prediction of Ocular Toxicity. Pharmaceutics 13:10, pages 1584.
Crossref
Hiba Ghura, Marin Keimer, Anja von Au, Norman Hackl, Verena Klemis & Inaam A. Nakchbandi. (2021) Inhibition of fibronectin accumulation suppresses tumor growth. Neoplasia 23:9, pages 837-850.
Crossref
François Sipieter, Benjamin Cappe, Aymeric Leray, Elke De Schutter, Jolien Bridelance, Paco Hulpiau, Guy Van Camp, Wim Declercq, Laurent Héliot, Pierre Vincent, Peter Vandenabeele & Franck B. Riquet. (2021) Characteristic ERK1/2 signaling dynamics distinguishes necroptosis from apoptosis. iScience 24:9, pages 103074.
Crossref
Joelle Mesmar, Manal M. Fardoun, Rola Abdallah, Yusra Al Dhaheri, Hadi M. Yassine, Rabah Iratni, Adnan Badran, Ali H. Eid & Elias Baydoun. (2021) Ziziphus nummularia Attenuates the Malignant Phenotype of Human Pancreatic Cancer Cells: Role of ROS. Molecules 26:14, pages 4295.
Crossref
Dingye Yu, Xiao Yang, Jianwei Lin, Zichao Cao, Chenghao Lu, Zheyu Yang, Minhua Zheng, Ruijun Pan & Wei Cai. (2021) Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer. Frontiers in Oncology 11.
Crossref
Feng Wang, Lan Zhang, Yue Xu, Yilin Xie & Shenglei Li. (2021) Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Carina Colturato-Kido, Rayssa M. Lopes, Hyllana C. D. Medeiros, Claudia A. Costa, Laura F. L. Prado-Souza, Letícia S. Ferraz & Tiago Rodrigues. (2021) Inhibition of Autophagy Enhances the Antitumor Effect of Thioridazine in Acute Lymphoblastic Leukemia Cells. Life 11:4, pages 365.
Crossref
Jose A. Colina, Katherine E. Zink, Kanella Eliadis, Reza Salehi, Emma S. Gargus, Sarah R. Wagner, Kristine J. Moss, Seth Baligod, Kailiang Li, Brenna J. Kirkpatrick, Teresa K. Woodruff, Benjamin K. Tsang, Laura M. Sanchez & Joanna E. Burdette. (2021) Fallopian Tube-Derived Tumor Cells Induce Testosterone Secretion from the Ovary, Increasing Epithelial Proliferation and Invasion. Cancers 13:8, pages 1925.
Crossref
Zoia Razumova, Husam Oda, Igor Govorov, Eva Lundin, Ellinor Östensson, David Lindquist & Miriam Mints. (2021) The Prognostic Role of LRIG Proteins in Endometrial Cancer. Cancers 13:6, pages 1361.
Crossref
Diana Montes-Grajales, Xiomara Morelos-Cortes & Jesus Olivero-Verbel. (2021) Discovery of New Protein Targets of BPA Analogs and Derivatives Associated with Noncommunicable Diseases: A Virtual High-Throughput Screening. Environmental Health Perspectives 129:3.
Crossref
Shu-Lun Jiang, Di-An Fang & Dong-Po Xu. (2021) Transcriptome changes of Takifugu obscurus liver after acute exposure to phenanthrene . Physiological Genomics 53:3, pages 116-124.
Crossref
Alessandro Medda, Daria Duca & Susanna Chiocca. (2021) Human Papillomavirus and Cellular Pathways: Hits and Targets. Pathogens 10:3, pages 262.
Crossref
Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Afshin Derakhshani, Nicola Silvestris, Amir Baghbanzadeh, Vito Racanelli & Behzad Baradaran. (2021) From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past. Frontiers in Immunology 12.
Crossref
Soyoung Hur, Eungyeong Jang & Jang-Hoon Lee. (2021) Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways. Nutrients 13:2, pages 555.
Crossref
Phillip C. Spinosa, Patrick C. Kinnunen, Brock A. Humphries, Gary D. Luker, Kathryn E. Luker & Jennifer J. Linderman. (2020) Pre-existing Cell States Control Heterogeneity of Both EGFR and CXCR4 Signaling. Cellular and Molecular Bioengineering 14:1, pages 49-64.
Crossref
Itishree Kaushik, Sharavan Ramachandran, Sahdeo Prasad & Sanjay K. Srivastava. (2021) Drug rechanneling: A novel paradigm for cancer treatment. Seminars in Cancer Biology 68, pages 279-290.
Crossref
Charles Oluwaseun Adetunji, Muhammad Akram, Andrew G. Mtewa, Jaison Jeevanandam, Chukwuebuka Egbuna, Alloysius Chibuike Ogodo, Ajay Kumar Gautam, Ashutosh Gupta, Peculiar Feenna Onyekere, Genevieve D. Tupas, Shahira M. Ezzat, Sunil Pareek, Habibu Tijjani, Nadia Sharif, Devaraj Ezhilarasan, Sadia Hassan, Narashans Alok Sagar, Abeer M. El Sayed, Mohammad Mehdizadeh, Merve Keskin, Chioma Obianuju Peculiar-Onyekere, Angelo Mark P. Walag, Priyanka Dhar, Abolanle A.A. Kayode, Ghulam Mohiudin, Khalil Ahmad, Shashank Kumar, Rida Zainab, Muhammad Kamran Khan, Muhammad Adil Farooq, Lisbeth Vallecilla-Yepez, Yusuf Abubakar & Ahmed Olatunde. 2021. Preparation of Phytopharmaceuticals for the Management of Disorders. Preparation of Phytopharmaceuticals for the Management of Disorders 307 360 .
Mingyu Luo, Yining Liu, Renfu Shao, Salma Begum Bhyan, YongKiat Wee & Min Zhao. (2020) Mutational analysis revealed 97 key cancer metastasis genes from extracellular vesicles associated with patient survival. Meta Gene 26, pages 100781.
Crossref
Shuhui Ouyang, Bo Jia, Wei Xie, Jing Yang & Yuncheng Lv. (2020) Mechanism underlying the regulation of sortilin expression and its trafficking function. Journal of Cellular Physiology 235:12, pages 8958-8971.
Crossref
Yu-Hong Li, Ying-Xue Li, Mu Li, Shao-wei Song, Yang Ge, Jun-yi Jin, Xiao-ying Li, Xiao-dong Tan & Jing Ye. (2020) The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer. Life Sciences 256, pages 117936.
Crossref
Johanna M. Buschhaus, Brock A. Humphries, Samantha S. Eckley, Tanner H. Robison, Alyssa C. Cutter, Shrila Rajendran, Henry R. Haley, Avinash S. Bevoor, Kathryn E. Luker & Gary D. Luker. (2020) Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow. Oncogene 39:34, pages 5649-5662.
Crossref
Iva Potočnjak, Lidija Šimić, Ivana Gobin, Iva Vukelić & Robert Domitrović. (2020) Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway. Toxicology in Vitro 66, pages 104852.
Crossref
Eun-Jin An, Yumi Kim, Seung-Hyeon Lee, Hyun Min Ko, Won-Seok Chung & Hyeung-Jin Jang. (2020) Anti-Cancer Potential of Oxialis obtriangulata in Pancreatic Cancer Cell through Regulation of the ERK/Src/STAT3-Mediated Pathway. Molecules 25:10, pages 2301.
Crossref
Wassim Shebaby, Andree Elias, Mohamad Mroueh, Bilal Nehme, Nahia Dib El Jalbout, Rita Iskandar, Joey C. Daher, Michelle Zgheib, Pascale Ibrahim, Vanessa Dwairi, Jean Michel Saad, Robin I. Taleb & Costantine F. Daher. (2020) Himachalol induces apoptosis in B16-F10 murine melanoma cells and protects against skin carcinogenesis. Journal of Ethnopharmacology 253, pages 112545.
Crossref
Abdulaziz B. Hamid & Ruben C. Petreaca. (2020) Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers 12:4, pages 927.
Crossref
Chen Chen, Lu Deng, De-Kang Nie, Feng Jia, Lin-Shan Fu, Zheng-Qiang Wan & Qing Lan. (2020) Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis. European Journal of Cancer Prevention 29:2, pages 165-173.
Crossref
Ping Huang, Bingli Qi, Hairong Yao, Liang Zhang, Yanying Li & Qian Li. (2020) Circular RNA cSMARCA5 regulates the progression of cervical cancer by acting as a microRNA‑432 sponge. Molecular Medicine Reports.
Crossref
Tatyana Kushnir, Shaked Bar-Cohen, Navit Mooshayef, Rotem Lange, Allan Bar-Sinai, Helit Rozen, Adi Salzberg, David Engelberg & Ze’ev Paroush. (2020) An Activating Mutation in ERK Causes Hyperplastic Tumors in a scribble Mutant Tissue in Drosophila . Genetics 214:1, pages 109-120.
Crossref
Pallabi Patowary, Dhruba K. Bhattacharyya & Pankaj Barah. (2020) Identifying critical genes in esophageal squamous cell carcinoma using an ensemble approach. Informatics in Medicine Unlocked 18, pages 100277.
Crossref
Qiu-Fang Qin, Xiao-Jun Li, Yu-Sang Li, Wei Kevin Zhang, Gui-Hua Tian, Hong-Cai Shang & He-Bin Tang. (2019) AMPK-ERK/CARM1 Signaling Pathways Affect Autophagy of Hepatic Cells in Samples of Liver Cancer Patients. Frontiers in Oncology 9.
Crossref
Mitsuru Futakuchi, Kris Lami, Yuri Tachibana, Yukari Yamamoto, Masahiro Furukawa & Junya Fukuoka. (2019) The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment. International Journal of Molecular Sciences 20:20, pages 5117.
Crossref
Qun Zhao, XianJun Yu, Ming Li, YongBo Liu, YaMei Han, XiXi Zhang, Xiao Ming Li, XiaoXia Wu, Jun Qin, Jing Fang & Haibing Zhang. (2019) MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses. Cancer Letters 459, pages 100-111.
Crossref
Xuepeng Fan, Mei Liu, Hao Tang, Dewen Leng, Shuli Hu, Rong Lu, Weibo Wan & Shiying Yuan. (2019) MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling. Journal of Surgical Research 240, pages 48-59.
Crossref
N. S. Finiuk, I. I. Ivasechko, O. Yu. Klyuchivska & Yu. V. Ostapiuk. (2019) Apoptosis induction in human leukemia cells by novel 2-amino-5-benzylthiazole derivatives. The Ukrainian Biochemical Journal 91:2, pages 29-39.
Crossref
Zhen-Mei Song, Fang Liu, Yan-Ming Chen, Yi-Jing Liu, Xiao-Di Wang & Shi-Yu Du. (2019) CTGF-mediated ERK signaling pathway influences the inflammatory factors and intestinal flora in ulcerative colitis. Biomedicine & Pharmacotherapy 111, pages 1429-1437.
Crossref
Chinmay Kumar Mantri & Ashley L. St. John. (2019) Immune synapses between mast cells and γδ T cells limit viral infection. Journal of Clinical Investigation 129:3, pages 1094-1108.
Crossref
Jun-I Wu, Yi-Pei Lin, Chien-Wei Tseng, Hui-Jane Chen & Lu-Hai Wang. (2019) Crabp2 Promotes Metastasis of Lung Cancer Cells via HuR and Integrin β1/FAK/ERK Signaling. Scientific Reports 9:1.
Crossref
Aniket Kumar Bansal, Laishram Rajendrakumar Singh & Majid Rasool Kamli. 2019. Protein Modificomics. Protein Modificomics 203 227 .
Simin Zhao, Yanan Jiang, Jimin Zhao, Honglin Li, Xueshan Yin, Yanhong Wang, Yifei Xie, Xinhuan Chen, Jing Lu, Ziming Dong & Kangdong Liu. (2018) Quercetin‐3‐methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways. Molecular Carcinogenesis 57:11, pages 1540-1552.
Crossref
Yan-Fen Feng, Yi-Yan Lei, Jia-Bin Lu, Shao-Yan Xi, Yu Zhang, Qi-Tao Huang, Qiu-Liang Wu & Fang Wang. (2018) RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death & Disease 9:11.
Crossref
Xiaoge Gao, Wenhua Shan, Xiangye Liu, Jian Zhang, Junnian Zheng & Hong Yao. (2018) JNK1/2 and ERK1/2 provides vital clues about tumor recurrence and survival in hepatocellular carcinoma patients. Future Oncology 14:24, pages 2471-2481.
Crossref
Hitoshi Sase, Yoshito Nakanishi, Satoshi Aida, Kana Horiguchi-Takei, Nukinori Akiyama, Toshihiko Fujii, Kiyoaki Sakata, Toshiyuki Mio, Masahiro Aoki & Nobuya Ishii. (2018) Acquired JHDM1D–BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2 -Amplified Gastric Cancer . Molecular Cancer Therapeutics 17:10, pages 2217-2225.
Crossref
Emmanuelle Bignon, Maria Francesca Allega, Marta Lucchetta, Matteo Tiberti & Elena Papaleo. (2018) Computational Structural Biology of S-nitrosylation of Cancer Targets. Frontiers in Oncology 8.
Crossref
Satoru Nagatoishi, Sou Yamaguchi, Etsuko Katoh, Keita Kajita, Takane Yokotagawa, Satoru Kanai, Toshio Furuya & Kouhei Tsumoto. (2018) A combination of 19F NMR and surface plasmon resonance for site-specific hit selection and validation of fragment molecules that bind to the ATP-binding site of a kinase. Bioorganic & Medicinal Chemistry 26:8, pages 1929-1938.
Crossref
Jeong‐Hyun Ryou, Yoo‐Kyoung Sohn, Dong‐Gun Kim, Hyun‐Ho Kyeong & Hak‐Sung Kim. (2018) Engineering and cytosolic delivery of a native regulatory protein and its variants for modulation of ERK2 signaling pathway. Biotechnology and Bioengineering 115:4, pages 839-849.
Crossref
Mifetika Lukitasari, Dwi Adi Nugroho & Nashi Widodo. (2018) Chlorogenic Acid: The Conceivable Chemosensitizer Leading to Cancer Growth Suppression. Journal of Evidence-Based Integrative Medicine 23, pages 2515690X1878962.
Crossref
Camille L. Duran, David W. Howell, Jui M. Dave, Rebecca L. Smith, Melanie E. Torrie, Jeffrey J. Essner & Kayla J. Bayless. 2011. Comprehensive Physiology. Comprehensive Physiology 153 235 .
Wassim N Shebaby, Mohamad A Mroueh, Petra Boukamp, Robin I Taleb, Kikki Bodman-Smith, Mirvat El-Sibai & Costantine F Daher. (2017) Wild carrot pentane-based fractions suppress proliferation of human HaCaT keratinocytes and protect against chemically-induced skin cancer. BMC Complementary and Alternative Medicine 17:1.
Crossref
Hongyu Guan, Zejun Guo, Weiwei Liang, Hai Li, Guohong Wei, Lijuan Xu, Haipeng Xiao & Yanbing Li. (2017) Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer 17:1.
Crossref
Robert D. Bongard, Michael Lepley, Khushabu Thakur, Marat R. Talipov, Jaladhi Nayak, Rachel A. Jones Lipinski, Chris Bohl, Noreena Sweeney, Ramani Ramchandran, Rajendra Rathore & Daniel S. Sem. (2017) Serendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor. BMC Biochemistry 18:1.
Crossref
Minjie Li, Sunkui Ke, Hongbing Duan & Chaohui Wu. (2017) Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro. Saudi Journal of Biological Sciences 24:8, pages 1859-1865.
Crossref
G. Sowmya Shree, K. Yogendra Prasad, H. S. Arpitha, U. R. Deepika, K. Nawneet Kumar, Priya Mondal & P. Ganesan. (2017) β-carotene at physiologically attainable concentration induces apoptosis and down-regulates cell survival and antioxidant markers in human breast cancer (MCF-7) cells. Molecular and Cellular Biochemistry 436:1-2, pages 1-12.
Crossref
Guojun Wang, Junfeng Sun, Guanghui Liu, Yang Fu & Xiefu Zhang. (2017) Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway. Journal of Cellular Biochemistry 118:12, pages 4444-4453.
Crossref
Haibo Pan, Fang Wang, Gary O. Rankin, Yon Rojanasakul, Youying Tu & Yi Charlie Chen. (2017) Inhibitory effect of black tea pigments, theaflavin-3/3′-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest. International Journal of Oncology 51:5, pages 1508-1520.
Crossref
R. V. D’Elia, R. J. Saint, S. L. Newstead, G. C. Clark & H. S. Atkins. (2017) Mitogen-activated protein kinases (MAPKs) are modulated during in vitro and in vivo infection with the intracellular bacterium Burkholderia pseudomallei. European Journal of Clinical Microbiology & Infectious Diseases 36:11, pages 2147-2154.
Crossref
Yan Chen, Jin Sun & Junyan Ma. (2017) Proliferation and invasion of ovarian cancer cells are suppressed by knockdown of TRIM11. Oncology Letters 14:2, pages 2125-2130.
Crossref
Hu Wang, Ying Zhang, Hailong Yun, Shubiao Chen, Yelong Chen & Zhaoyong Liu. (2017) ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma. Oncotarget 8:28, pages 45249-45258.
Crossref
Song Park, Yonghun Sung, Jain Jeong, Minjee Choi, Jinhee Lee, Wookbong Kwon, Soyoung Jang, Si Jun Park, Hyeng-Soo Kim, Mee-Hyun Lee, Dong Joon Kim, Kangdong Liu, Sung-Hyun Kim, Zigang Dong, Zae Young Ryoo & Myoung Ok Kim. (2017) hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways. Oncotarget 8:23, pages 37115-37127.
Crossref
Min Deng, Yiyu Qin, Xiaodong Chen, Dapeng Li, Qiangwu Wang, Hailun Zheng, Lin Gu, Chaojing Deng, Yongju Xue, Danyu Zhu, Qizhi Wang & Jianchao Wang. (2017) Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation. Oncology Letters 13:5, pages 3850-3858.
Crossref
Xiaoyu Li, Yi Liu, Cuiping Zhang, Qinghui Niu, Hui Wang, Cong Che, Man Xie, Bin Zhou, Yonghong Xu, Qi Zhang, Jun Wu & Zibin Tian. (2017) Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway. Oncotarget 8:10, pages 16356-16366.
Crossref
Rebeca Manso, Giovanna Roncador, Santiago Montes-Moreno, Federico Rojo, M. Ángeles Pérez-Sáenz, Manuela Mollejo, Javier Menárguez, Nerea Carvajal, Mónica García-Cosio, Pilar Llamas, Miguel A. Piris & Socorro M. Rodríguez-Pinilla. (2017) p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients. British Journal of Haematology 176:4, pages 661-664.
Crossref
Rebeca Kawahara, Daniela Campos Granato, Sami Yokoo, Romênia Ramos Domingues, Daniel Maragno Trindade & Adriana Franco Paes Leme. (2017) Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. Journal of Proteomics 151, pages 53-65.
Crossref
Haifeng Wang, Kan Gao, Ke Wen, Irving Coy Allen, Guohua Li, Wenming Zhang, Jacob Kocher, Xingdong Yang, Ernawati Giri-Rachman, Guan-Hong Li, Sherrie Clark-Deener & Lijuan Yuan. (2016) Lactobacillus rhamnosus GG modulates innate signaling pathway and cytokine responses to rotavirus vaccine in intestinal mononuclear cells of gnotobiotic pigs transplanted with human gut microbiota. BMC Microbiology 16:1.
Crossref
Zoi Piperigkou, Panagiotis Bouris, Maurizio Onisto, Marco Franchi, Dimitris Kletsas, Achilleas D. Theocharis & Nikos K. Karamanos. (2016) Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules. Matrix Biology 56, pages 4-23.
Crossref
Emma J. Haagensen, Huw D. Thomas, Wolfgang A. Schmalix, Andrew C. Payne, Lara Kevorkian, Rodger A. Allen, Paul Bevan, Ross J. Maxwell & David R. Newell. (2016) Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037. Cancer Chemotherapy and Pharmacology 78:6, pages 1269-1281.
Crossref
Wen-Lun Wang, Wei-Lun Chang, Hsiao-Bai Yang, Yu-Chi Wang, I-Wei Chang, Ching-Tai Lee, Chi-Yang Chang, Jaw-Town Lin & Bor-Shyang Sheu. (2016) Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma. Oncotarget 7:44, pages 71169-71181.
Crossref
Pandima Devi Kasi, Rajavel Tamilselvam, Krystyna Skalicka-Woźniak, Seyed Fazel Nabavi, Maria Daglia, Anupam Bishayee, Hamidreza Pazoki-toroudi & Seyed Mohammad Nabavi. (2016) Molecular targets of curcumin for cancer therapy: an updated review. Tumor Biology 37:10, pages 13017-13028.
Crossref
Tal Goshen-Lago, Anat Goldberg-Carp, Dganit Melamed, Ilona Darlyuk-Saadon, Chen Bai, Natalie G. Ahn, Arie Admon & David Engelberg. (2016) Variants of the yeast MAPK Mpk1 are fully functional independently of activation loop phosphorylation. Molecular Biology of the Cell 27:17, pages 2771-2783.
Crossref
Mohammed I. Khan, Konrad J. Dębski, Michał Dabrowski, Anna M. Czarnecka & Cezary Szczylik. (2016) Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line. American Journal of Physiology-Renal Physiology 311:2, pages F424-F436.
Crossref
Hsin-Lin Cheng, Ming-Ju Hsieh, Jia-Sin Yang, Chiao-Wen Lin, Ko-Haung Lue, Ko-Hsiu Lu & Shun-Fa Yang. (2016) Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget 7:23, pages 35208-35223.
Crossref
Wei Lijuan, Jin Xiaoying, Cao Zipei & Li Wenlu. (2016) Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways. Journal of Traditional Chinese Medicine 36:3, pages 353-359.
Crossref
Valentina Salizzato, Christian Borgo, Luca Cesaro, Lorenzo A. Pinna & Arianna Donella-Deana. (2016) Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies. Oncotarget 7:14, pages 18204-18218.
Crossref
LIXIN JIANG, HAIDI CHU & HAITAO ZHENG. (2016) B-Raf mutation and papillary thyroid carcinoma patients. Oncology Letters 11:4, pages 2699-2705.
Crossref
Karina Smorodinsky-Atias, Tal Goshen-Lago, Anat Goldberg-Carp, Dganit Melamed, Alexei Shir, Navit Mooshayef, Jonah Beenstock, Yael Karamansha, Ilona Darlyuk-Saadon, Oded Livnah, Natalie G. Ahn, Arie Admon & David Engelberg. (2016) Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation. Molecular Biology of the Cell 27:6, pages 1026-1039.
Crossref
Yaman Arkun. (2016) Dynamic Modeling and Analysis of the Cross-Talk between Insulin/AKT and MAPK/ERK Signaling Pathways. PLOS ONE 11:3, pages e0149684.
Crossref
Rui Jiang, Chunming Zhao, Hao Xu, Miaoqing Zhao, Xiaogang Sun, Xinyu Wang & Wei Song. (2015) Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma . Clinical Endocrinology 84:3, pages 431-437.
Crossref
Gilcy George K & Girija Kuttan. (2016) Inhibition of pulmonary metastasis by Emilia sonchifolia (L.) DC: An in vivo experimental study. Phytomedicine 23:2, pages 123-130.
Crossref
Amir Mehdizadeh, Mohammad Hossein Somi, Masoud Darabi & Mortaza Jabbarpour-Bonyadi. (2016) Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. Molecular Biology Reports 43:2, pages 107-116.
Crossref
Jemal Adem, Antti Ropponen, Jonna Eeva, Mine Eray, Ulla Nuutinen & Jukka Pelkonen. (2016) Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis. Journal of Immunotherapy 39:1, pages 8-14.
Crossref
Terrence S. Neumann, Elise A. Span, Kelsey S. Kalous, Robert Bongard, Adam Gastonguay, Michael A. Lepley, Raman G. Kutty, Jaladhi Nayak, Chris Bohl, Rachel G. Lange, Majher I. Sarker, Marat R. Talipov, Rajendra Rathore, Ramani Ramchandran & Daniel S. Sem. (2015) Identification of inhibitors that target dual-specificity phosphatase 5 provide new insights into the binding requirements for the two phosphate pockets. BMC Biochemistry 16:1.
Crossref
Matteo S. Carlino, Georgina V. Long, Richard F. Kefford & Helen Rizos. (2015) Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma. Critical Reviews in Oncology/Hematology 96:3, pages 385-398.
Crossref
Koji Tsumagari, Zakaria Y. Abd Elmageed, Andrew B. Sholl, Paul Friedlander, Mohamed Abdraboh, Mingzhao Xing, A. Hamid Boulares & Emad Kandil. (2015) Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer. Cancer Letters 368:1, pages 46-53.
Crossref
Adrianna Sławińska-Brych, Sylwia Katarzyna Król, Magdalena Dmoszyńska-Graniczka, Barbara Zdzisińska, Andrzej Stepulak & Mariusz Gagoś. (2015) Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro. Chemico-Biological Interactions 240, pages 110-118.
Crossref
Arman Ghorbani, Hamid Zand, Mahmood Jeddi-Tehrani, Fariba Koohdani, Farzad Shidfar & Seyed Ali Keshavarz. (2015) PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress. Journal of Natural Medicines 69:4, pages 507-512.
Crossref
Aswathi A. George, Helicia Paz, Fei Fei, Jonathan Kirzner, Yong-mi Kim, Nora Heisterkamp & Hisham Abdel-Azim. (2015) Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia. PLOS ONE 10:9, pages e0137917.
Crossref
Lu Gan, Zhenjiang Liu, Wei Jin, Zhongjie Zhou & Chao Sun. (2015) Foxc2 enhances proliferation and inhibits apoptosis through activating Akt/mTORC1 signaling pathway in mouse preadipocytes. Journal of Lipid Research 56:8, pages 1471-1480.
Crossref
Annie-Pier Beauregard, Jason Harquail, Grégoire Lassalle-Claux, Mehdi Belbraouet, Jacques Jean-Francois, Mohamed Touaibia & Gilles Robichaud. (2015) CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells. Molecules 20:7, pages 12576-12589.
Crossref
Mi Jung Kim & Hyeyoung Kim. (2015) Anticancer Effect of Lycopene in Gastric Carcinogenesis. Journal of Cancer Prevention 20:2, pages 92-96.
Crossref
Ramin SamadaniJun ZhangAmanda BrophyTaiji OashiU. Deva PriyakumarE. Prabhu RamanFranz J. St JohnKwan-Young JungSteven FletcherEdwin PozharskiAlexander D. MacKerellJrJrPaul Shapiro. (2015) Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf. Biochemical Journal 467:3, pages 425-438.
Crossref
JIE CHEN, ZHIJUN WANG, DANFENG XU, YUSHAN LIU & YI GAO. (2015) Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion. Molecular Medicine Reports 11:4, pages 2882-2888.
Crossref
Marie-Laure Bonnefond, Bernard Lambert, Florence Giffard, Edwige Abeilard, Emilie Brotin, Marie-Hélène Louis, Mor Sény Gueye, Pascal Gauduchon, Laurent Poulain & Monique N’Diaye. (2015) Calcium signals inhibition sensitizes ovarian carcinoma cells to anti-Bcl-xL strategies through Mcl-1 down-regulation. Apoptosis 20:4, pages 535-550.
Crossref
Heng-Jing Hu, Sheng-Hua Zhou & Qi-Ming Liu. (2015) Treatment of pheochromocytoma blockade of MAPK pathway inhibition in the NF-κB pathway and bFGF — Effect of statins on pheochromocytoma patients. International Journal of Cardiology 182, pages 161-162.
Crossref
Shiyi Yu, Xiuxiu Cai, Chenxi Wu, Lele Wu, Yuzhi Wang, Yan Liu, Zhenghong Yu, Sheng Qin, Fei Ma, Jean Paul Thiery & Liming Chen. (2014) Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression. Oncotarget 6:5, pages 2951-2965.
Crossref
Wei-Rui Ma & Jian Zhang. (2015) Jag1b is essential for patterning inner ear sensory cristae by regulating anterior morphogenetic tissue separation and preventing posterior cell death. Development 142:4, pages 763-773.
Crossref
Wen Wen Xu, Bin Li, Alfred KY Lam, Sai Wah Tsao, Simon YK Law, Kwok Wah Chan, Qiu Ju Yuan & Annie LM Cheung. (2014) Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. Oncotarget 6:3, pages 1790-1805.
Crossref
Juanfei WangJinqi RenBin WuShanshan FengGuoping CaiFlorin Tuluc, Johan Peränen & Wei Guo. (2014) Activation of Rab8 guanine nucleotide exchange factor Rabin8 by ERK1/2 in response to EGF signaling. Proceedings of the National Academy of Sciences 112:1, pages 148-153.
Crossref
Ruixia Guo, Xinyan Wang, Ruifang Zhang, Huirong Shi, Yuhuan Qiao, Wenjing Yun, Xin Ge, Yan Lin & Jia Lei. (2015) Response of Subcutaneous Xenografts of Endometrial Cancer in Nude Mice to Inhibitors of Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase (MAPK) Pathways: An Effective Therapeutic Strategy for Endometrial Cancer. Journal of Cancer Therapy 06:12, pages 1083-1092.
Crossref
Wenjing Sun, Chao Quan, Yun Huang, Wei Ji, Lisa Yu, Xinxin Li, Yang Zhang, Zhibo Zheng, Hongyan Zou, Quanxiao Li, Ping Xu, Yan Feng, Li Li, Yunyan Zhang, Yunfu Cui, Xueyuan Jia, Xiangning Meng, Chunyu Zhang, Yan Jin, Jing Bai, Jingcui Yu, Yang Yu, Jianhua Yang & Songbin Fu. (2014) Constitutive ERK1 /2 activation contributes to production of double minute chromosomes in tumour cells . The Journal of Pathology 235:1, pages 14-24.
Crossref
Ken CN Chang & Matthew J Marton. (2014) Past, current and future approaches to querying MAPK pathway activation: status and clinical implications. Personalized Medicine 11:8, pages 745-760.
Crossref
Ge Yang, Yang Fu, Margarita Malakhova, Igor Kurinov, Feng Zhu, Ke Yao, Haitao Li, Hanyong Chen, Wei Li, Do Young Lim, Yuqiao Sheng, Ann M. Bode, Ziming Dong & Zigang Dong. (2014) Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis. Cancer Prevention Research 7:10, pages 1056-1066.
Crossref
Edward Ottley & Elspeth Gold. (2014) microRNA and non-canonical TGF-β signalling: Implications for prostate cancer therapy. Critical Reviews in Oncology/Hematology 92:1, pages 49-60.
Crossref
Julio Villena, Hisashi Aso & Haruki Kitazawa. (2014) Regulation of Toll-Like Receptors-Mediated Inflammation by Immunobiotics in Bovine Intestinal Epitheliocytes: Role of Signaling Pathways and Negative Regulators. Frontiers in Immunology 5.
Crossref
Mei Mei, Dan Xie, Yi Zhang, Jing Jin, Feng You, Yan Li, Jungui Dai & Xiaoguang Chen. (2014) A New 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) Derivative Overcomes Paclitaxel Resistance by Inhibiting MAPK Signaling and Increasing Paclitaxel Accumulation in Breast Cancer Cells. PLoS ONE 9:8, pages e104317.
Crossref
Giorgio Baruchello & Elísabet Hjörleifsdóttir. (2014) Social Philosophy and Oncology. Social Theory & Health 12:3, pages 313-338.
Crossref
Shiby Kuriakose & Jude E. Uzonna. (2014) Diminazene aceturate (Berenil), a new use for an old compound?. International Immunopharmacology 21:2, pages 342-345.
Crossref
Shao-Chieh Lin, Wan-Lin Liao, Jenq-Chang Lee & Shaw-Jenq Tsai. (2014) Hypoxia-regulated gene network in drug resistance and cancer progression. Experimental Biology and Medicine 239:7, pages 779-792.
Crossref
Depu Zhang, Xiaowei Li, Ziming Yao, Chuanfei Wei, Nannan Ning & Jingxin Li. (2014) GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Cancer Letters 348:1-2, pages 100-108.
Crossref
Stephanie M. J. Fliedner, Tobias Engel, Nikoletta K. Lendvai, Uma Shankavaram, Svenja Nölting, Robert Wesley, Abdel G. Elkahloun, Hendrik Ungefroren, Angela Oldoerp, Gary Lampert, Hendrik Lehnert, Henri Timmers & Karel Pacak. (2014) Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells. PLoS ONE 9:5, pages e97712.
Crossref
Ikko Kajihara, Masatoshi Jinnin, Miho Harada, Katsunari Makino, Noritoshi Honda, Takamitsu Makino, Toshikatsu Igata, Shinichi Masuguchi, Satoshi Fukushima & Hironobu Ihn. (2014) miR-205 down-regulation promotes proliferation of dermatofibrosarcoma protuberans tumor cells by regulating LRP-1 and ERK phosphorylation. Archives of Dermatological Research 306:4, pages 367-374.
Crossref
Xiao-Bin Lv, Xing Zhang, Lan Deng, Ling Jiang, Wei Meng, Zhigang Lu & Xiuju Wang. (2014) MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim. Cell Biology International 38:4, pages 435-443.
Crossref
Guihong Huang, Bo Tang, Kun Tang, Xiaomin Dong, Jungang Deng, Luqin Liao, Zengzhen Liao, Hua Yang & Songqing He. (2014) Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. Oncology Reports.
Crossref
Takeshi Ito, Suguru Yamada, Chie Tanaka, Sachiko Ito, Toshifumi Murai, Daisuke Kobayashi, Tsutomu Fujii, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Shuji Nomoto, Michitaka Fujiwara & Yasuhiro Kodera. (2013) Overexpression of L1CAM is Associated with Tumor Progression and Prognosis via ERK Signaling in Gastric Cancer. Annals of Surgical Oncology 21:2, pages 560-568.
Crossref
Y Sun, W Guo, T Ren, W Liang, W Zhou, Q Lu, G Jiao & T Yan. (2014) Gli1 inhibition suppressed cell growth and cell cycle progression and induced apoptosis as well as autophagy depending on ERK1/2 activity in human chondrosarcoma cells. Cell Death & Disease 5:1, pages e979-e979.
Crossref
Ruining Zhang, Suyun Liu, Bingyan Guo, Liang Chang & Yongjun Li. (2014) Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway. Pharmacology 94:5-6, pages 259-264.
Crossref
E. Mauriz, S. Carbajo-Pescador, R. Ordoñez, M. C. García-Fernández, J. L. Mauriz, L. M. Lechuga & J. González-Gallego. (2014) On-line surface plasmon resonance biosensing of vascular endothelial growth factor signaling in intact-human hepatoma cell lines. The Analyst 139:6, pages 1426.
Crossref
Joseph S. Maffei, Jaya Srivastava, Brian Fallica & Muhammad H. Zaman. (2014) Combinative in vitro studies and computational model to predict 3D cell migration response to drug insult. Integr. Biol. 6:10, pages 957-972.
Crossref
JIANJUAN MA, XIYING YU, LIPING GUO & SHIH HSIN LU. (2013) DUSP6, a tumor suppressor, is involved in differentiation and apoptosis in esophageal squamous cell carcinoma. Oncology Letters 6:6, pages 1624-1630.
Crossref
Juliana Carvalho Santos, André Uchimura Bastos, Janete Maria Cerutti & Marcelo Lima Ribeiro. (2013) Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma. BMC Cancer 13:1.
Crossref
Emad Kandil, Koji Tsumagari, Jingjing Ma, Zakaria Y. Abd Elmageed, Xinying Li, Douglas Slakey, Debasis Mondal & Asim B. Abdel-Mageed. (2013) Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. Journal of Surgical Research 184:2, pages 898-906.
Crossref
Ju-Hwa Kim, Ae-Ran Choi, Yong Kim, Hyung Kim & Sungpil Yoon. (2013) Low Amount of Salinomycin Greatly Increases Akt Activation, but Reduces Activated p70S6K Levels. International Journal of Molecular Sciences 14:9, pages 17304-17318.
Crossref
Hongge Cheng, Jie Meng, Guisheng Wang, Yuming Meng, Yu Li, Dong Wei, Chunyun Fu, Kaifeng Deng, Aiguo Shen, Huimin Wang & Shengming Dai. (2013) Skp2 Regulates Subcellular Localization of PPARγ by MEK Signaling Pathways in Human Breast Cancer. International Journal of Molecular Sciences 14:8, pages 16554-16569.
Crossref
Qunyan Jin, Guangming Liu, Phillip P. Domeier, Wei Ding & Kathleen M. Mulder. (2013) Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells. PLoS ONE 8:6, pages e66439.
Crossref
J.J. Dong, Y. Zhou, Y.T. Liu, Z.W. Zhang, X.J. Zhou, H.J. Wang & L. Liao. (2013) In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma. Molecular and Cellular Endocrinology 370:1-2, pages 113-118.
Crossref
Huizi Lei, Dongling Zou, Zheng Li, Min Luo, Lei Dong, Bin Wang, Haixin Yin, Yanni Ma, Changzheng Liu, Fang Wang, Junwu Zhang, Jia Yu & Yu Li. (2013) MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation. PLoS ONE 8:4, pages e60369.
Crossref
Chunning Zheng, Xuelong Jiao, Yingsheng Jiang & Shaochuan Sun. (2013) ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. Journal of International Medical Research 41:2, pages 300-306.
Crossref
Toshiaki Sakamoto, Kei-ichi Ozaki, Kohsuke Fujio, Shu-hei Kajikawa, Shin-ichi Uesato, Kazushi Watanabe, Susumu Tanimura, Takehiko Koji & Michiaki Kohno. (2013) Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. Biochemical and Biophysical Research Communications 433:4, pages 456-462.
Crossref
Kozue Murata, Julio Villena, Yohsuke Tomosada, Risa Hara, Eriko Chiba, Tomoyuki Shimazu, Hisashi Aso, Yoshihito Suda, Noriyuki Iwabuchi, Jin-Zhong Xiao, Tadao Saito & Haruki Kitazawa. (2013) Bifidobacteria Upregulate Expression of Toll-Like Receptor Negative Regulators Counteracting Enterotoxigenic <i>Escherichia coli</i> Mediated Inflammation in Bovine Intestinal Epitheliocytes. Open Journal of Veterinary Medicine 03:02, pages 143-155.
Crossref
David W. Chan, Winnie W. Y. Hui, Patty C. H. Cai, Michelle X. Liu, Mingo M. H. Yung, Celia S. L. Mak, Thomas H. Y. Leung, Karen K. L. Chan & Hextan Y. S. Ngan. (2012) Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells. PLoS ONE 7:12, pages e52578.
Crossref
Huansheng Yang, Fengna Li, Xiangfeng Kong, Xiaoxue Yuan, Wence Wang, Ruilin Huang, Tiejun Li, Meimei Geng, Guoyao Wu & Yulong Yin. (2012) Chemerin regulates proliferation and differentiation of myoblast cells via ERK1/2 and mTOR signaling pathways. Cytokine 60:3, pages 646-652.
Crossref
Giulia RomanoMario AcunzoMichela GarofaloGianpiero Di LevaLuciano CascioneCiro Zanca, Brad Bolon, Gerolama Condorelli & Carlo M. Croce. (2012) MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation. Proceedings of the National Academy of Sciences 109:41, pages 16570-16575.
Crossref
Qi Zhou, Meng Zhu, Hao Zhang, Ting Yi, John D. Klena & Yihong Peng. (2012) Disruption of the p53–p21 pathway inhibits efficiency of the lytic-replication cycle of herpes simplex virus type 2 (HSV-2). Virus Research 169:1, pages 91-97.
Crossref
Gerold Bongers, Luciana R. Muniz, Michelle E. Pacer, Alina C. Iuga, Nanthakumar Thirunarayanan, Erik Slinger, Martine J. Smit, E. Premkumar Reddy, Lloyd Mayer, Glaucia C. Furtado, Noam Harpaz & Sergio A. Lira. (2012) A Role for the Epidermal Growth Factor Receptor Signaling in Development of Intestinal Serrated Polyps in Mice and Humans. Gastroenterology 143:3, pages 730-740.
Crossref
Mitra Heravi, Nada Tomic, LiHeng Liang, Slobodan Devic, Joseph Holmes, François Deblois, Danuta Radzioch & Thierry Muanza. (2012) Sorafenib in combination with ionizing radiation has a greater anti-tumour activity in a breast cancer model. Anti-Cancer Drugs 23:5, pages 525-533.
Crossref
Elena Ercolesi, Gabriella Tedeschi, Gabriella Fiore, Armando Negri, Elisa Maffioli, Marco d’Ischia & Anna Palumbo. (2012) Protein nitration as footprint of oxidative stress-related nitric oxide signaling pathways in developing Ciona intestinalis. Nitric Oxide 27:1, pages 18-24.
Crossref
R Minelli, L Serpe, P Pettazzoni, V Minero, G Barrera, CL Gigliotti, R Mesturini, AC Rosa, P Gasco, N Vivenza, E Muntoni, R Fantozzi, U Dianzani, GP Zara & C Dianzani. (2012) Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. British Journal of Pharmacology 166:2, pages 587-601.
Crossref
Jinqi Ren & Wei Guo. (2012) ERK1/2 Regulate Exocytosis through Direct Phosphorylation of the Exocyst Component Exo70. Developmental Cell 22:5, pages 967-978.
Crossref
Josephine Hai, Chang-Qi Zhu, Bizhan Bandarchi, Yu-Hui Wang, Roya Navab, Frances A. Shepherd, Igor Jurisica & Ming-Sound Tsao. (2012) L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer. Clinical Cancer Research 18:7, pages 1914-1924.
Crossref
E J Haagensen, S Kyle, G S Beale, R J Maxwell & D R Newell. (2012) The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition. British Journal of Cancer 106:8, pages 1386-1394.
Crossref
Won-Jin Moon, Nami Choi, Jin Woo Choi, Suk Kyeong Kim & Tae Sook Hwang. (2012) BRAF Mutation Analysis and Sonography as Adjuncts to Fine-Needle Aspiration Cytology of Papillary Thyroid Carcinoma: Their Relationships and Roles . American Journal of Roentgenology 198:3, pages 668-674.
Crossref
Hiroshi Hirata, Yuji Hinoda, Koji Ueno, Koichi Nakajima, Nobuhisa Ishii & Rajvir Dahiya. (2012) MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. Carcinogenesis 33:3, pages 501-508.
Crossref
Takumi Kawabata, Susumu Tanimura, Kohei Asai, Ryohei Kawasaki, Yumi Matsumaru & Michiaki Kohno. (2012) Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor. Journal of Biological Chemistry 287:13, pages 10289-10300.
Crossref
Antonio Garofalo, Amaury Farce, Séverine Ravez, Amélie Lemoine, Perrine Six, Philippe Chavatte, Laurence Goossens & Patrick Depreux. (2012) Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors. Journal of Medicinal Chemistry 55:3, pages 1189-1204.
Crossref
Yasuhiro Ito & Akira Miyauchi. (2012) Prognostic Factors of Papillary and Follicular Carcinomas in Japan Based on Data of Kuma Hospital. Journal of Thyroid Research 2012, pages 1-18.
Crossref
Hiroshi Hirata, Yuji Hinoda, Koji Ueno, Varahram Shahryari, Z.Laura Tabatabai & Rajvir Dahiya. (2012) MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 33:1, pages 41-48.
Crossref
Bo Wang, Hao Zhang, Meng Zhu, Zhijun Luo & Yihong Peng. (2012) MEK1–ERKs signal cascade is required for the replication of Enterovirus 71 (EV71). Antiviral Research 93:1, pages 110-117.
Crossref
Khalid M. AlGhamdi, Ashok Kumar & Noura A. Moussa. (2011) Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers in Medical Science 27:1, pages 237-249.
Crossref
Andrea Piserchio, Kevin N. Dalby & Ranajeet Ghose. 2012. Protein NMR Techniques. Protein NMR Techniques 359 368 .
Gabriela Lavezzari & Mark R. Lackner. 2012. Kinase Inhibitors. Kinase Inhibitors 203 215 .
Sarice R Boston, Rahul Deshmukh, Scott Strome, U Deva Priyakumar, Alexander D MacKerellJrJr & Paul Shapiro. (2011) Characterization of ERK Docking Domain Inhibitors that Induce Apoptosis by Targeting Rsk-1 and Caspase-9. BMC Cancer 11:1.
Crossref
Daniele Maggioni, Renato Gaini, Gabriella Nicolini, Giovanni Tredici & Werner Garavello. (2011) MAPKs activation in head and neck squamous cell carcinomas. Oncology Reviews 5:4, pages 223-231.
Crossref
Raúl A. Ruggiero, Juan Bruzzo, Paula Chiarella, Pedro di Gianni, Martín A. Isturiz, Susana Linskens, Norma Speziale, Roberto P. Meiss, Oscar D. Bustuoabad & Christiane D. Pasqualini. (2011) Tyrosine Isomers Mediate the Classical Phenomenon of Concomitant Tumor Resistance. Cancer Research 71:22, pages 7113-7124.
Crossref
Daniel Barr, Taiji Oashi, Kimberly Burkhard, Sarah Lucius, Ramin Samadani, Jun Zhang, Paul Shapiro, Alexander D. MacKerellJr.Jr. & Arjan van der Vaart. (2011) Importance of Domain Closure for the Autoactivation of ERK2. Biochemistry 50:37, pages 8038-8048.
Crossref
Ayesha B. Alvero, Michele K. Montagna, Jennie C. Holmberg, Vinicius Craveiro, David Brown & Gil Mor. (2011) Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells. Molecular Cancer Therapeutics 10:8, pages 1385-1393.
Crossref
Aaron C. Tan, De-Xing Hou, Izabela Konczak, Shunsuke Tanigawa, Iqbal Ramzan & Daniel M.-Y. Sze. (2011) Native Australian fruit polyphenols inhibit COX-2 and iNOS expression in LPS-activated murine macrophages. Food Research International 44:7, pages 2362-2367.
Crossref
Marlène Maitre, Valérie Roullot-Lacarrière, Pier Vincenzo Piazza & Jean-Michel Revest. (2011) Western blot detection of brain phosphoproteins after performing Laser Microdissection and Pressure Catapulting (LMPC). Journal of Neuroscience Methods 198:2, pages 204-212.
Crossref
Mingzhao Xing & Paul Ladenson. 2011. Thyroid Cancer. Thyroid Cancer 27 38 .
Andrea Piserchio, Mangalika Warthaka, Ashwini K. Devkota, Tamer S. Kaoud, Sunbae Lee, Olga Abramczyk, Pengyu Ren, Kevin N. Dalby & Ranajeet Ghose. (2011) Solution NMR Insights into Docking Interactions Involving Inactive ERK2. Biochemistry 50:18, pages 3660-3672.
Crossref
Shih-Chieh Lin, Chun-Wei Chien, Jenq-Chang Lee, Yi-Chun Yeh, Keng-Fu Hsu, Yen-Yu Lai, Shao-Chieh Lin & Shaw-Jenq Tsai. (2011) Suppression of dual-specificity phosphatase–2 by hypoxia increases chemoresistance and malignancy in human cancer cells. Journal of Clinical Investigation 121:5, pages 1905-1916.
Crossref
Susumu Tanimura, Junya Hashizume, Yukiko Kurosaki, Kanako Sei, Aiko Gotoh, Rika Ohtake, Michihiro Kawano, Kazushi Watanabe & Michiaki Kohno. (2011) SH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation. Genes to Cells 16:5, pages 514-526.
Crossref

Displaying 200 of 295 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.